MBM

Ventegra Announces it is First to Earn CAA Certification from HPfid’s Compliance Program Designed to Meet the Fiduciary Compliance Requirements of the Consolidated Appropriations Act

Retrieved on: 
星期二, 五月 21, 2024
Technology, Consulting, Professional Services, Health Insurance, Software, Practice Management, Managed Care, Pharmaceutical, Health, Data Management, ERISA, MBM, CPA, Omnibus spending bill, CAA, Software as a service, MBA, Certification, HR, JD, Pharming, PBM, Pharmacy, Multimedia, Health insurance

View the full release here: https://www.businesswire.com/news/home/20240521920054/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240521920054/en/
    The Consolidated Appropriations Act, 2021 (CAA) established protections for consumers related to surprise billing and transparency in health care.
  • HPfid is a CAA Compliance SaaS platform that helps employers comply with the Consolidated Appropriations Act, 2021 (CAA) .
  • Robert T. Taketomo, Pharm.D., MBA, President/CEO, enthuses, “Ventegra is honored to be the first healthcare company in the pharmacy benefits space to be awarded this CAA certification.
  • Any entity applying for certification would get a scorecard of their level of CAA compliance, and obtain an understanding of any requirements necessary to attain CAA certification from the HPfid program.

Ventegra Announces the Successful Implementation of the New Ventegra Specialty Inclusion (VSI) Program

Retrieved on: 
星期三, 五月 1, 2024
Technology, Consulting, Professional Services, Health Insurance, Software, Practice Management, Managed Care, Pharmaceutical, Health, Data Management, Pharmacy, Probability, Safety, Explanation, Plasma protein binding, MBM, Pharming, MBA, Pharmacist, VSI

The VSI program underscores Ventegra’s clinical infrastructure and heritage as a company managed and operated predominantly by healthcare professionals, pharmacists, and certified pharmacy technicians.

Key Points: 
  • The VSI program underscores Ventegra’s clinical infrastructure and heritage as a company managed and operated predominantly by healthcare professionals, pharmacists, and certified pharmacy technicians.
  • Mark Shinmoto, Pharm.D., Chief Pharmacy Officer, says, “The Ventegra Specialty Inclusion (VSI) program’s capability is a vital and important new tool in Ventegra’s ability to appropriately manage the utilization of the plethora of drugs being brought to market.
  • Robert T. Taketomo, Pharm.D., MBA, President/CEO, explains, “The Ventegra Specialty Inclusion program reflects the clinical focus of Ventegra and our deep commitment to member care and managed care principles.
  • Unlike most traditional pharmacy benefit managers, Ventegra does not have any fiduciary commitment to shareholders and exists to serve and benefit its community.

Cranfill Sumner Launches MBM in Washington, D.C., with Partners Patrick Mincey and Stephen Bell and Christina Zaroulis Milnor, Former Assistant Secretary of the SEC

Retrieved on: 
星期三, 五月 1, 2024
Consulting, Professional Services, Legal, United Nations, University, General counsel, Truth Social, Financial Crimes Enforcement Network, Social media, Lawyer, Comptroller, Kremlin, Vladimir Putin, Security (finance), False Claims Act, Intelligence, B.A, MBM, DOJ, Bell, Multimedia, Assistant, Currency, Government, Harvard University, PDVSA

The new group, Mincey Bell Milnor (MBM) will focus on white collar, regulatory enforcement, high-stakes civil litigation, and representation of whistleblowers before federal agencies.

Key Points: 
  • The new group, Mincey Bell Milnor (MBM) will focus on white collar, regulatory enforcement, high-stakes civil litigation, and representation of whistleblowers before federal agencies.
  • “With MBM, we have landed a prominent government official, just exiting the SEC, paired with two nationally known white collar litigators.
  • We set it up this way so these lawyers could have the visibility of a boutique group with the platform of our larger firm.
  • We plan to continue to grow the practice from here.”
    Milnor has held significant roles at the SEC for more than a decade.

NEW STUDY FINDS NINE IN TEN CANADIANS SUPPORT A FULLY FUNDED CANADA DISABILITY BENEFIT.

Retrieved on: 
星期一, 四月 8, 2024
MP, CDB, Disability, Organization, Letter, Angus Reid (entrepreneur), Federation, Partnership, Dignity, Poverty, Food, Parliament, MBM, ARI, Government, NDP, Daily Bread Food Bank, Health insurance

Although results found overwhelming support for the benefit, Canadians are critical of the pace of implementation and do not trust that government will follow through.

Key Points: 
  • Although results found overwhelming support for the benefit, Canadians are critical of the pace of implementation and do not trust that government will follow through.
  • The Canada Disability Benefit has the potential to be one of Canada's most important programs and could lift nearly one million Canadians out of poverty if fully funded."
  • For Canadians concerned about government debt, a fully funded benefit will reduce these downstream costs, all while helping Canadians with disabilities live a life of dignity.
  • Over 200,000 letters have been sent to MPs across the country expressing support for a fully funded Canada Disability Benefit.

Ventegra Launches Ventegra Access Program (VAP)

Retrieved on: 
星期一, 四月 1, 2024
Technology, Software, Philanthropy, Practice Management, Biotechnology, Managed Care, General Health, Pharmaceutical, Health, Foundation, VAP, Patient, Pharmacy, Sale, Business development, MBM, Pharmaceutical industry

Ventegra, Inc., a Medical Benefit Manager (MBM) that delivers innovative, cost-efficient pharmaceutical and healthcare solutions to payors, providers, and patients, today announced the launch of the Ventegra Access Program (VAP).

Key Points: 
  • Ventegra, Inc., a Medical Benefit Manager (MBM) that delivers innovative, cost-efficient pharmaceutical and healthcare solutions to payors, providers, and patients, today announced the launch of the Ventegra Access Program (VAP).
  • The program underscores Ventegra’s deep understanding of the value of the coordinated care delivery model and serves the needs of those with similar goals and objectives.
  • Brian Vossler, Vice President, Business Development, says, “The Ventegra Access Program (VAP) is a vital and important evolution on a point-of-sale rebate program that delivers the net contract cost to the payor at the point of adjudication.
  • The Ventegra business model was designed to fundamentally realign financial incentives focusing on value-based care and total healthcare cost.

Ventegra Announces Third-Party Audit Validation of Its Robo-Rebate® Software

Retrieved on: 
星期三, 三月 6, 2024
Health, Health Technology, Practice Management, Other Health, Managed Care, Pharmaceutical, Pharmacy, Pharmacy technician, Growth, MBA, Patient, Pharming, MPH, MBM, Health insurance

A world’s top 5 ranked pharmaceutical manufacturer recently completed a detailed audit of Ventegra using a large third-party auditor.

Key Points: 
  • A world’s top 5 ranked pharmaceutical manufacturer recently completed a detailed audit of Ventegra using a large third-party auditor.
  • They conducted two separate audits on submissions generated by Ventegra’s proprietary Robo-Rebate software resulting in zero financial impact to Ventegra and Ventegra’s clients.
  • The audit reviewed millions of dollars in complex medical benefit claims spanning Ventegra’s largest clients and risk-bearing medical groups (approaching 200 distinct entities).
  • Ventegra’s Robo-Rebate software tracks rebate growth and savings with true transparency to help clients maximize savings while supporting quality care.

Mercedes-Benz Financial Services Canada Corporation appoints Brian Stevens as new President and CEO

Retrieved on: 
星期二, 三月 5, 2024
Professional Services, Automotive, Automotive Manufacturing, Other Automotive, Manufacturing, Finance, CFO, CPA, Structured finance, Multimedia, Joint venture, Athlon, Digital, Mercedes-Benz Group, Comptroller, MBM, EQ, Mercedes-Benz, Ernst & Young, Mercedes-Benz Bank, Duke University, Benelux, LLP, Mobility, Controller, Mercedes-Benz Mobility, Insurance, FREE, Grand Valley State University, DCS

Mercedes-Benz Financial Services Canada Corporation (MBFS), a leading automotive financial services provider and a Mercedes-Benz Mobility AG (MBM) company, is pleased to announce the appointment of Brian Stevens as its new President and CEO as of the fourth quarter 2023.

Key Points: 
  • Mercedes-Benz Financial Services Canada Corporation (MBFS), a leading automotive financial services provider and a Mercedes-Benz Mobility AG (MBM) company, is pleased to announce the appointment of Brian Stevens as its new President and CEO as of the fourth quarter 2023.
  • View the full release here: https://www.businesswire.com/news/home/20240304532618/en/
    Brian Stevens, President and CEO, Mercedes-Benz Financial Services Canada Corporation (Photo: Business Wire)
    In this role, he will lead the Canadian operations of MBM in succession of James Ryan, who was appointed CEO of Mercedes-Benz Financial Services BeNeLux, leading MBM operations in the Belgium, Netherlands and Luxembourg markets, last year.
  • "Brian brings more than a decade of experience with the Canadian market following his successful tenure as Chief Financial Officer of MBM NA.
  • Mercedes-Benz Financial Services Canada at a glance:
    Mercedes-Benz Financial Services Canada Corporation, located in Mississauga, Ontario, supports the sales efforts of Mercedes-Benz passenger cars and vans in Canada by offering premier financial services to retail customers and the dealer network.

Ventegra Announces Its ‘Great Place to Work®’ Certification

Retrieved on: 
星期四, 二月 1, 2024
DEI (Diversity, Equity and Inclusion), Pharmaceutical, Human Resources, Managed Care, Health, Health Technology, Professional Services, Other Health, Patient, Doctor of Pharmacy, MBA, MBM, Organization, Nursing

Ventegra, Inc., a Medical Benefit Manager (MBM) that delivers innovative, cost-efficient pharmaceutical and healthcare solutions to payors, providers, and patients, has earned the designation as a 2024 Great Place to Work-Certified™ Company, announces Robert T. Taketomo, PharmD, MBA, President & CEO of Ventegra, Inc., and Chairman of the Board of the Ventegra Foundation.

Key Points: 
  • Ventegra, Inc., a Medical Benefit Manager (MBM) that delivers innovative, cost-efficient pharmaceutical and healthcare solutions to payors, providers, and patients, has earned the designation as a 2024 Great Place to Work-Certified™ Company, announces Robert T. Taketomo, PharmD, MBA, President & CEO of Ventegra, Inc., and Chairman of the Board of the Ventegra Foundation.
  • The designation was awarded to Ventegra by the Great Place to Work Institute, Inc., the world’s most trusted authority on workplace culture with a mission to help organizations become great workplaces For All™.
  • Says Dr. Taketomo, “The certification marks the first time Ventegra has sought and earned this highly coveted, special honor that recognizes Ventegra as a superior workplace and spotlights Ventegra’s remarkable innovative and collaborative work-life balance culture, our high-trust, integrity-driven work experience, and unsurpassed employee pride.”
    In making the announcement, Dr. Taketomo adds, “As we continue to grow and approach being a company with 200 employees, becoming a Great Place to Work-Certified™ company is a testament to what we hold paramount to our success!
  • It is a truly rewarding acknowledgement of our Ventegra culture that is at the center of our brand identity and purpose as we celebrate our 20th anniversary and our historic transition, which began January 3, 2024, from being a California Benefit Corporation into Ventegra Foundation, a California Nonprofit Public Benefit Corporation.”
    Employee feedback through the Great Place to Work survey confirmed that 100% of Ventegra employees believe Ventegra is a safe place to work, 97% of Ventegra employees believe that at Ventegra people are treated fairly regardless of their race, age, and gender, 97% of Ventegra employees say they feel a sense of pride at what they accomplish, and 94% say they feel good about the way they contribute to the national community.

Ventegra, Inc. Announces Transition Into California Nonprofit Public Benefit Corporation – Launch of Ventegra Foundation Aligned With Ventegra’s 100-Year Strategy

Retrieved on: 
星期二, 一月 9, 2024
Other Health, General Health, Professional Services, Pharmaceutical, Technology, Health Insurance, Insurance, Biotechnology, Practice Management, Other Technology, Consulting, Health, PBM, Pharming, Patient, Pharmacy, Administrative Science, MD, MBM, University, Risk, MBA, University of New Mexico

Ventegra, Inc., a Medical Benefit Manager (MBM) that delivers innovative, cost-efficient pharmaceutical solutions to payors, providers, and patients, announces that it began its historic transition January 3, 2024, from being a California Benefit Corporation into Ventegra Foundation, a California Nonprofit Public Benefit Corporation.

Key Points: 
  • Ventegra, Inc., a Medical Benefit Manager (MBM) that delivers innovative, cost-efficient pharmaceutical solutions to payors, providers, and patients, announces that it began its historic transition January 3, 2024, from being a California Benefit Corporation into Ventegra Foundation, a California Nonprofit Public Benefit Corporation.
  • The State of California has previously approved the issuance of the Articles of Incorporation for Ventegra Foundation, and it is expected to be fully operational by June 30, 2024.
  • Ventegra supports programs that a traditional Pharmacy Benefits Manager (PBM) will not because of the conflicts of interest that are endemic in healthcare administrative services.
  • The new Ventegra Foundation is uniquely positioned to change that dynamic at scale.”

VEGZELMA® (bevacizumab-adcd) receives preferred formulary status with Ventegra® for commercially insured patients

Retrieved on: 
星期一, 十二月 11, 2023
Urine, Reproduction, Skeleton, Headache, PSA, Kidney, Erythroderma, Patient, Pharmacy, Birth, Nephrotic syndrome, MBA, Cancer, Miscarriage, Safety, Incidence, VTE, Bevacizumab, Corneal opacity, Wound healing, VEGFR2, Gastrointestinal perforation, Hemoptysis, Female, Fetus, CHF, Celltrion, Pharming, Necrotizing fasciitis, Heart failure, Fistula, Risk, Tracheoesophageal fistula, Bleeding, Organogenesis, Partnership, Rhinitis, Hypertension, Primary ovarian insufficiency, Back pain, Pregnancy, Glioblastoma, PRES, Nosebleed, Skull, FDA, ATE, VEGF, MBM, Hypertensive encephalopathy, Toxicity, Nursing, Pharmaceutical industry, Birth control, Dietary supplement, Proteinuria

Ventegra's proprietary formulary program (which includes Formulary Shield and the Ventegra Specialty Inclusion Program) is available for access by more than 400 clients and 13 million members/patients that are enrolled with Ventegra.

Key Points: 
  • Ventegra's proprietary formulary program (which includes Formulary Shield and the Ventegra Specialty Inclusion Program) is available for access by more than 400 clients and 13 million members/patients that are enrolled with Ventegra.
  • Gastrointestinal Perforations and Fistula: Discontinue for gastrointestinal perforations, tracheoesophageal fistula, grade 4 fistula, or fistula formation involving any organ.
  • Surgery and Wound Healing Complications: In patients who experience wound healing complications during VEGZELMA treatment, withhold VEGZELMA until adequate wound healing.
  • Do not administer VEGZELMA for at least 28 days following a major surgery, and until adequate wound healing.